Expanded clinical target volume and survival in non-operative ESCC: Prognostic benefits and inflammatory risks
Although inflammatory biomarkers offer prognostic value, primary GTV-CTV margin expansion has a stronger influence on LRFS in ESCC patients undergoing CRT. Further multi-institutional studies are needed to validate these findings and address current study limitations, including single-center design, small sample size and exclusion of in-field recurrences.
Authors
- Yan Cheng (ORCID: https://orcid.org/0000-0002-7019-052X)
- Dizhi Jiang
- Hongyuan Mao
- Xinyue Ma
- Zerun Li
- Kaiyue Guo
- Chenhan Huang
- Xinyu Zhang
- Wenhao Cheng
Institutions
- Shandong Provincial Hospital (CN)
- Qilu Hospital of Shandong University (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Advances in Clinical and Experimental Medicine
- Published
- 2026-02-23
- DOI
- https://doi.org/10.17219/acem/203882
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China